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Aconitase, the second enzyme of the tricarboxylic acid cycle encoded by ACO1 in the budding yeast Saccharomyces cerevisiae,
catalyzes the conversion of citrate to isocitrate. aco1Δ results in mitochondrial DNA (mtDNA) instability. It has been proposed that
Aco1 binds to mtDNA and mediates its maintenance. Here we propose an alternative mechanism to account for mtDNA loss in
aco1Δ mutant cells. We found that aco1Δ activated the RTG pathway, resulting in increased expression of genes encoding citrate
synthase. By deleting RTG1, RTG3, or genes encoding citrate synthase, mtDNA instability was prevented in aco1Δ mutant cells.
Increased activity of citrate synthase leads to iron accumulation in the mitochondria. Mutations in MRS3 and MRS4, encoding
two mitochondrial iron transporters, also prevented mtDNA loss due to aco1Δ. Mitochondria are the main source of superoxide
radicals, which are converted toH
2
O
2
through two superoxide dismutases, Sod1 and Sod2.H
2
O
2
in turn reacts with Fe2+ to generate
very active hydroxyl radicals. We found that loss of Sod1, but not Sod2, prevents mtDNA loss in aco1Δ mutant cells. We propose
that mtDNA loss in aco1Δ mutant cells is caused by the activation of the RTG pathway and subsequent iron citrate accumulation
and toxicity.
1. Introduction
Respiratory metabolism in eukaryotes requires proteins
encoded in both the nuclear genome and the mitochondrial
genome (mtDNA).Mitochondrial genomes generally encode
a small number of proteins, many of which are involved
in respiratory metabolism [1, 2]. Maintenance of mtDNA is
important for cell growth and survival. Oxidative damage to
mtDNA causes respiratory deficiency and human diseases
[3–5]. In higher eukaryotes, how the mitochondrial genome
is maintained and transmitted is not well understood. How-
ever, studies using the budding yeast Saccharomyces cerevisiae
have generated an abundance of data on how its mitochon-
drial genome is maintained [6, 7]. Many nuclear-encoded
proteins of diverse functions are required for mtDNA main-
tenance. When mtDNA is mutated, yeast cells form the so-
called “petite” mutants. Yeast can be categorized as those with
wild type (rho+ cells), extensively deleted (rho− petites), or
with complete loss of (rho0 petites) mtDNA. How mutations
in nuclear genes cause defects in mtDNA maintenance is
complex and often indirect. For example, mutations in the
yeast homolog of frataxin, Yfh1, lead to iron overload in
mitochondria, defects in maturation of proteins containing
iron-sulfur clusters such as the TCA cycle enzyme aconitase,
mtDNA instability and respiratory deficiency, and so forth
[8–10]. Yeast studies have suggested that iron citrate toxicity
may be responsible for yfh1 mutant phenotypes [11, 12]. Respi-
ratory metabolism generates reactive oxygen species such as
superoxide radicals. Superoxide dismutases, Sod1 and Sod2,
localized in the cytoplasm andmitochondria, respectively, are
responsible for converting superoxide radicals to relatively
harmless hydrogen peroxide [13], which can react with fer-
rous iron (Fe2+) to generate highly reactive hydroxyl radicals
through the Fenton reaction.Hydrogen peroxide is detoxified
by enzymes such as catalases, converting hydrogen peroxide
to oxygen and water [14]. Mutations in yeast catalases and
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superoxide dismutase lead to oxidative damage and reduced
resistance to oxidants [14–16].
Besides resulting in respiratory deficiency, mutations in
TCA cycle enzyme encoding genes also lead to variable
defects inmtDNAmaintenance [17, 18].Themost severe phe-
notype is caused by mutations in the ACO1 gene encoding
aconitase, followed by the IDH1 gene encoding a subunit
of mitochondrial isocitrate dehydrogenase [19]. It has been
proposed that Aco1 has a novel function in mediating
mtDNA maintenance by directly binding mtDNA [20, 21].
Mutations in ACO1 and IDH1 share several growth defect
phenotypes, which can be partially rescued by mutations in
CIT1, encoding the mitochondrial isoform of citrate synthase
[17]. Expression ofCIT1,ACO1, IDH1, and IDH2 is under dual
control of two transcriptional regulatory complexes, Rtg1/3
and Hap2/3/4/5 [22]. In cells with reduced or defective respi-
ratory functions, expression of these genes is under increased
control of Rtg1/3. Rtg1 and Rtg3 are two basic helix-loop-
helix transcription factors in the retrograde response pathway
that mediates signaling from mitochondria to the nucleus
[23]. Activation of Rtg1/3 requires a cytoplasmic protein,
Rtg2, which has an N-terminal ATP binding domain in the
Hsp70/actin/sugar kinase ATP binding domain superfamily
[24]. The retrograde response pathway, also known as the
RTGpathway, is activated in response to defects inmitochon-
drial respiratory function. Cit1, Aco1, and Idh1/2 promote
synthesis of 𝛼-ketoglutarate, a precursor of glutamate, which
is a potent repressor of the RTG pathway [23]. Mutations in
ACO1, which lead to both a block in mitochondrial respira-
tory function and glutamate auxotrophy [25–27], therefore,
likely activate the RTG pathway. However, it is not clear
whether the RTG pathway contributes to the phenotypes of
aco1 mutants.
Mutations in RTG2 and CIT2 have been reported to
suppress mtDNA instability due to mutations in YFH1 [12].
In this study, we provide an alternative model to account for
mtDNA loss due to an aco1Δmutation. We found that muta-
tions in either RTG genes, genes encoding citrate synthases,
genes encoding mitochondrial iron transporters, or SOD1
suppress aco1Δ-induced mtDNA loss. Therefore, we propose
that iron citrate toxicity contributes to aco1Δ mutant pheno-
types.
2. Materials and Methods
2.1. Strains, Plasmids, Growth Media, and Growth Conditions.
Yeast strains and plasmids used in this study are listed
in Tables 1 and 2, respectively. Yeast mutant strains were
created by either direct transformation with gene knock-
out cassettes or through meiotic segregation analysis of
heterozygous diploids. Mutations were confirmed by PCR-
genotyping, standard genotyping based on selectionmarkers,
phenotypic analysis, and/or immunoblotting using antibody
against Aco1. The BY4741 rho0 strain was generated by one
passage of rho+ cells grown in YPD medium supplemented
with 15 𝜇g/mL ethidium bromide. Yeast cells were grown in
SD (0.67% yeast nitrogen base plus 2% dextrose), YNBCasD
(SDmedium plus 1% casamino acids), YNBcasR (0.67% yeast
nitrogen base, 1% casamino acids, and 2% raffinose), YPD
(1% yeast extract, 2% peptone, 2% dextrose), or YPEthanol
(1% yeast extract, 2% peptone, 2% ethanol) medium at 30∘C.
When necessary, amino acids, adenine, and/or uracil were
added to the growth medium at standard concentrations to
cover auxotrophic requirements [28].
2.2. Yeast Transformation and𝛽-GalactosidaseActivityAssays.
Plasmids were transformed into yeast strains using the high-
efficiency lithium acetate-PEG method and 𝛽-galactosidase
assays were carried out as described [28]. For each plasmid
and strain combination, assays were conducted in duplicates,
and independent experiments were carried out two times.
Specific activity of 𝛽-galactosidase is expressed as nmols of
𝑜-nitrophenol generated from substrate 𝑜-nitrophenyl-𝛽-D-
galactoside per min per mg protein.
2.3. DAPI Staining of Nuclear and Mitochondrial DNA and
FLuorescence Microscopy. DAPI (4󸀠6,-diamidino-2-phenyl-
indole) staining of nuclear and mitochondrial DNA was
carried out as described [28]. Briefly, yeast strains were grown
in liquid YPD or YNBcasD medium at 30∘C overnight to
𝐴
600
∼ 0.8. Cells were collected by centrifugation and treated
with 1𝜇g/mL DAPI in 95% ethanol for 30min and cell pellets
were washed with sterile water three times. DAPI-stained
DNA molecules in fixed cells were observed by fluorescence
microscopy using aNikonEclipse E800microscope equipped
with an HBO 100W/2 mercury arc lamp, a Nikon Plan Fluor
100X objective lens, and epifluorescence with a Nikon UV-
2E/C filter set (excitation 340–380 nm and emission 435–
485 nm). Digital images were acquired with Photometrics
Coolsnap fx CCD camera andMetamorph Imaging Software
(Molecular Devices, Sunnyvale, CA) and processed using
ImageJ (National Institutes of Health) and Adobe Photoshop
(Mountain View, CA).
2.4. Citrate Analysis. Cells were grown in 10mL YPD
medium overnight to ∼OD
600
1.0. Cultures were chilled in
ice-cold water for 22min and cells were collected by centrifu-
gation at 4∘C. Cell pellets were then washed twice in chilled
water. Citrate levels were determined using a citrate assay kit
(BioVision, CA, USA). Cells were disrupted in 500𝜇L Assay
Buffer in the kit using glass beads method. Cell extract was
clarified by centrifugation at 21,000 g at 4∘C for 15min. 20 uL
cell extract was analyzed for protein concentration using
Bradford assay and the rest of cell extract (∼350) was depro-
teinized in Amicon Ultra 4 column (10 kDa cutoff). Depro-
teinized extract was analyzed for citrate levels according to
the protocol provided by the manufacturer. Citrate levels in
different strains were normalized by protein concentration
of cellular extract prior to deproteinization. Citrate concen-
tration in the wild-type strain was 7.97 nmols/mg proteins,
which was arbitrarily set as 1 unit. Citrate concentration in
the wild-type strain determined in this study is similar to
∼1.1 nmols/107 cells reported previously [12].
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Table 1: Strains used in this study.
Strain Genotype Source
BY4741 MATa ura3 leu2 his3 met15 Research genetics
BY4731 MATa ura3 leu2 met15 Research genetics
BY4742 MATa ura3 leu2 his3 lys2 Research genetics
BY4741 (rho0) BY4741 rho0 derivative This study
ZLY2630 BY4741 aco1::kanMX4 This study
ZLY1264 BY4741 rtg1::kanMX4 Research genetics
ZLY1267 BY4741 rtg2::kanMX4 Research genetics
ZLY1273 BY4741 rtg3::kanMX4 Research genetics
ZLY2568 BY4742 rtg1::LEU2 This study
ZLY143 BY4731 rtg2::LEU2 This study
ZLY2570 BY4742 rtg3::URA3 This study
ZLY2648 BY4741 rtg1::LEU2 aco1::kanMX4 This study
ZLY2631 BY4741 rtg2::LEU2 aco1::kanMX4 This study
ZLY2652 BY4741 rtg3::URA3 aco1::kanMX4 This study
ZLY3206 MAT𝛼met? [rho0] This study
CS725-3A MATa ura3 leu2 his3 met15 cit1/2/3::kanMX4 [21]
ZLY2545 CS725-3A aco1::HIS3 [21]
RBY353 BY4741 cit1::kanMX4 Research genetics
RBY355 BY4741 cit2::kanMX4 Research genetics
RBY356 BY4741 cit3::kanMX4 Research genetics
ZLY2603 MATa ura3 leu2 met15 aco1::kanMX4 This study
RBY469 BY4741 cit1::kanMX4 aco1::kanMX4 This study
RBY277 BY4741 cit2::kanMX4 aco1::kanMX4 This study
RBY363 BY4741 cit3::kanMX4 aco1::kanMX4 This study
ZLY854 BY4741 cit1/2::kanMX4 aco1::kanMX4 This study
BY4741 (mrs3 mrs4) BY4741mrs3::kanMX4 mrs4::kanMX4 [29]
ZLY3505 BY4741mrs3::kanMX4 mrs4::kanMX4 aco1::HIS3 This study
ZLY4603 BY4741 sod1::kanMX4 This study
BY4741 (sod2) BY4741 sod2::kanMX4 Research genetics
TPY1507 BY4741 sod1::kanMX4 aco1::kanMX4 This study
ZLY3973 BY4741 sod2::kanMX4 aco1::kanMX4 This study
Table 2: Plasmids used in this study.
Plasmid Description Source
pRS416 A yeast centromeric plasmid carrying URA3 selection marker [30]
pUC-rtg1::LEU2 An rtg1::LEU2 disruption cassette in pUC19 [31]
pUC-rtg2::LEU2 An rtg2::LEU2 disruption cassette in pUC19 [31]
pUC-rtg3::URA3 An rtg3::URA3 disruption cassette in pUC19 [32]
pBS-aco1::HIS3 An aco1::HIS3disruption cassette in pBluescript This study
pCIT2-lacZ A CIT2-lacZ reporter gene on the plasmid pWCJ (CEN URA3) This study
pRS303-SOD1 The SOD1 gene was cloned into the integrative plasmid pRS303 This study
3. Results and Discussion
3.1. aco1Δ Activates the RTG Pathway. Mutations in ACO1
lead to both respiratory deficiency and glutamate starvation,
which are expected to activate the RTG pathway. To test this
possibility, we determined the effect of an aco1Δmutation on
the expression of a CIT2-lacZ reporter gene, which has been
used extensively as a readout of the activity of the RTG path-
way [22, 24, 33–35]. Expression of CIT2-lacZ was assessed in
wild-type rho+ and aco1Δmutant cells using 𝛽-galactosidase
assays. Since aco1Δ cells are rho0 petites, we also determined
CIT2-lacZ expression in otherwise wild-type rho0 cells. Cells
were grown in rich media with either raffinose or dextrose
(D-glucose) as the sole carbon source, which have been used
in studies on the RTG pathway and mitochondrial genome
maintenance, respectively [12, 20, 21, 36]. In cells grown in
raffinose medium, CIT2-lacZ expression was 4-fold higher in
rho0 cells compared to rho+ cells, consistent with previous
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Figure 1:The RTG pathway is activated in aco1Δmutant cells grown
in dextrose medium.Wild-type rho+ (WT, BY4741), its rho0 deriva-
tive, and aco1Δ (ZLY2603) mutant strains were transformed with a
centromeric plasmid encoding a CIT2-lacZ reporter gene (pCIT2-
lacZ) and transformants were grown in YNBcasR (Raffinose) and
YNBcasD (Dextrose) medium tomid-logarithmic phase. Cells were
collected and 𝛽-galactosidase assays were conducted as described in
Section 2.
reports that the RTG pathway is activated in rho0 cells
[33, 36]. An aco1Δ mutation induced CIT2-lacZ expression
slightly higher than in wild-type rho0 cells (Figure 1). In cells
grown in dextrose medium, CIT2-lacZ expression in rho0
cells is only marginally higher than in rho+ cells, whereas
an aco1Δ mutation almost doubled CIT2-lacZ expression.
Activation of the RTG pathway is strain dependent [37]. The
lack of induction of the RTG pathway due to loss of mtDNA
in dextrose-grown BY4741 background strains used in this
study can be partly attributed to a doubling of CIT2-lacZ
expression in rho+ cells grown in this medium compared to
raffinose medium, which is consistent with activation of the
RTGpathway due to compromisedmitochondrial respiratory
function since dextrose suppresses respiratory metabolism in
yeast. Altogether, these data indicate that an aco1Δ mutation
leads to activation of the RTG pathway.
3.2. Mutations in RTG Genes Prevent mtDNA Loss due to
aco1Δ. To determine whether activation of the RTG pathway
in aco1Δ mutant cells contributes to mtDNA loss, rtg1Δ
aco1Δ, rtg2Δ aco1Δ, and rtg3Δ aco1Δ double mutants were
constructed and examined for the presence or absence of
mtDNA. These double mutant strains were created by cross-
ing respective haploid mutant strains to form heterozygous
diploid mutants, which were then sporulated to generate
desired haploid segregants. Seven rtg1Δ aco1Δ, seven rtg2Δ
aco1Δ, and six rtg3Δ aco1Δ double mutant segregants were
obtained. Eight aco1Δ single mutant segregants were also
isolated similarly. DAPI, a DNA-specific probe that forms a
fluorescent complex [38], was then used to visualize mtDNA
using fluorescence microscopy in these mutants along with
wild-type rho+ and rho0 strains. In addition to nuclear DNA,
DAPI staining revealed punctate cytoplasmic structures of
mtDNA in wild-type rho+ cells grown in YPD medium
(Figure 2(a)) [38]. In contrast, mtDNA was absent in both
wild-type rho0 and aco1Δ mutant cells, consistent with pre-
vious reports that Aco1 is required for mtDNA maintenance
[17, 18, 21]. Interestingly, mtDNA was maintained in rtg1Δ
aco1Δ, rtg2Δ aco1Δ, and rtg3Δ aco1Δ double mutant strains,
indicating that Rtg proteins mediate mtDNA instability in
aco1Δ mutant cells. The percentage of rho0 cells was quan-
tified from DAPI-stained images and a large majority of rtgΔ
aco1Δ double mutant cells were found to contain mtDNA
(Figure 2(b)). Among seven rtg2Δ aco1Δ double mutant seg-
regants from heterozygous rtg2Δ/RTG2 aco1Δ/ACO1 diploid
mutant cells, all were found to maintain mtDNA. Similarly,
all of the seven rtg1Δ aco1 and six rtg3Δ aco1Δ double mutant
segregants were also found to be rho+ cells. In contrast, all of
the eight aco1Δ single mutant segregants from a heterozygous
aco1Δ/ACO1 diploid mutant have lost mtDNA. Together, our
data suggest that mtDNA instability in aco1Δ mutant cells
may result from activation of the RTG pathway.
Damages to mtDNA can lead to extensive deletions
(rho−) or point mutations (mit−) [6, 7]. Yeast strains that
carry these two types of mutant mitochondrial genomes
are respiratory deficient. To determine whether the mtDNA
in the rtgΔ aco1Δ double mutant strains is functional, we
conducted a complementation assay by crossing wild-type
rho+, wild-type rho0, rtg1Δ, rtg2Δ, rtg3Δ, rtg1Δ aco1Δ, rtg2Δ
aco1Δ, and rtg3Δ aco1Δ mutant strains to a rho0 tester strain
of opposite mating type with wild-type nuclear ACO1 gene
and analyzing the respiratory capacity of the resultant diploid
strains. rtg1Δ aco1Δ, rtg2Δ aco1Δ, and rtg3Δ aco1Δ mutant
strains were unable to utilize carbon sources that require
respiratory metabolism such as ethanol because they are
defective in the TCA cycle (data not shown), and Figure 2(c)
shows that diploids generated from crossing wild-type rho+,
rtg1Δ, rtg2Δ, and rtg3Δ strains with the rho0 tester strain were
able to grow on ethanol medium. In contrast, diploids from
crosses involving wild-type rho0 or the aco1Δ single mutant
were unable to grow on ethanol medium, consistent with the
absence of mtDNA in these diploids. Remarkably, diploids
generated from the rho0 tester strain and rtgΔ aco1Δ double
mutants were able to grow on ethanol medium, indicating
that mtDNA in rtgΔ aco1Δ cells are functional.
3.3. Mutations in Genes Encoding Citrate Synthase, Primarily
CIT1, Prevent mtDNA Loss due to aco1Δ. What is the mech-
anism of aco1Δ suppression by mutations in RTG genes? The
RTG pathway is required for glutamate biosynthesis in cells
with reduced respiratory function by regulating expression of
CIT1, CIT2, ACO1, IDH1, and IDH2 [23]. It has been shown
previously that a cit1Δmutation partially suppresses mtDNA
loss in aco1Δ mutant cells and that mutations in CIT2 and
RTG2 rescue respiratory deficiency in yfh1Δ mutant cells
[12, 17]. Three genes, CIT1, CIT2, and CIT3, encode citrate
synthase in yeast, with CIT1 and CIT3 encoding the two
mitochondrial isoforms and CIT2 encoding the peroxisomal
isoform [39–41]. Therefore, suppression of mtDNA loss in
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Figure 2: mtDNA is maintained in rtg1Δ aco1, rtg2Δ aco1Δ, and rtg3Δ aco1Δ mutant cells. (a) Cells grown exponentially in YPD medium
were stained with DAPI and then examined using fluorescence microscopy. WT (rho+), BY4741; WT (rho0), BY4741 rho0; aco1Δ, ZLY2630;
rtg1Δ aco1Δ, ZLY2648; rtg2Δ aco1Δ, ZLY2631; rtg3Δ aco1Δ, ZLY2652. (b) Quantitative analysis of the percentage of rho0 cells in yeast strains
based on DAPI-staining images. (c) mtDNA in rtgΔ aco1Δ double mutant cells is functional. Strains as described in (a) as well as rtg1Δ, rtg2Δ,
and rtg3Δ single mutants were crossed to a rho0 tester strain (X rho0) of opposite mating type. Diploids were selected and grown on YPD
(Dextrose) and YPEthanol (Ethanol) medium. Pictures of cells were taken after 3 days’ growth at 30∘C.
rtg1Δ aco1Δ, rtg2Δ aco1Δ, and rtg3Δ aco1Δ double mutant
cells may be due to reduced expression of genes encoding
citrate synthase. To confirm this possibility, we introduced
an aco1Δ mutation into a cit1Δ cit2Δ cit3Δ triple mutant in
the BY4741 strain background generated by Chen et al. [21].
Thepresence or absence ofmtDNA in the resultant quadruple
mutant cells was examined by DAPI staining and fluores-
cencemicroscopy. Figure 3(a) shows that the cit1Δ cit2Δ cit3Δ
aco1Δ quadruple mutant maintained mtDNA. To determine
which citrate synthase-encoding gene(s) is responsible for
mtDNA loss in aco1Δmutant cells, we generated cit1Δ aco1Δ,
cit2Δ aco1Δ, and cit3Δ aco1Δ double mutants, as well as an
aco1Δ cit1Δ cit2Δ triple mutant by crossing respective haploid
mutant strains followed by meiotic segregation analysis.
Using DAPI staining and fluorescence microscopy, we found
that six out of eight cit1Δ aco1Δ double mutants, zero out of
six cit2Δ aco1Δ double mutants, zero out of six cit3Δ aco1Δ
double mutants, and six out of six cit1Δ cit2Δ aco1Δ triple
mutant strains maintained mtDNA (Figure 3 and data not
shown). We also calculated the percentage of rho0 cells in
a cit1Δ aco1Δ double, a cit1Δ cit2Δ aco1Δ triple, and a cit1Δ
cit2Δ cit3Δ aco1Δ quadruple mutant and found that over 90%
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(b)
Figure 3:Mutations in genes encoding citrate synthase preventmtDNA loss due to aco1Δ. (a) Cells grown inYPDmedium tomid-logarithmic
phase were stainedwithDAPI and examined using fluorescencemicroscopy.WT (rho+), BY4741; aco1Δ, ZLY2630; cit1Δ aco1Δ, RBY469; cit2Δ
aco1Δ, RBY277; cit1Δ cit2Δ aco1Δ, ZLY854; cit1Δ cit2Δ cit3Δ aco1Δ, ZLY854; rtg2Δ aco1Δ, ZLY2545. (b) Quantitative analysis of the percentage
of rho0 cells in yeast strains based on DAPI-staining images.
WT (rho+) aco1Δ mrs3Δ mrs4Δ aco1Δ
Figure 4: Mutations in MRS3 and MRS4, encoding mitochondrial
iron transporters, prevent mtDNA loss due to aco1Δ. Cells grown
in YPD medium to mid-logarithmic phase were stained with DAPI
and examined using fluorescence microscopy. WT (rho+), BY4741;
aco1Δ, ZLY2630;mrs3Δmrs4Δ aco1Δ, ZLY3505.
cells from these mutants maintained mtDNA (Figure 3(b)).
Taken together, these data suggest that citrate synthase is the
target of the RTG pathway that mediates mtDNA instability
in aco1Δ mutant cells and that Cit1 is primarily responsible
for this phenotype in the BY4741 strain background.
3.4. Mutations in Genes Encoding Mitochondrial Iron Trans-
porters Mrs3 and Mrs4 Prevent mtDNA Loss due to aco1Δ.
It has been proposed that iron citrate toxicity contributes
to oxidative damage and mtDNA loss in yfh1Δ mutant cells,
which have higher levels of cellular and mitochondrial iron
[8, 12]. Mutations in RTG2 and CIT2 reduce petite formation
in yfh1Δ mutants by lowering cellular citrate and iron lev-
els. Suppression of mtDNA loss in aco1Δ mutant cells by
mutations in RTG genes and genes encoding citrate synthase
prompted us to test whether mitochondrial iron overload is
responsible for mtDNA instability in aco1Δ mutants. Mito-
chondrial iron transport is mediated by iron transporters
Mrs3 and Mrs4 [11, 29, 42, 43], mutations of which rescue
mtDNA loss in yfh1Δ mutants. To this end, we generated an
mrs3Δ mrs4Δ aco1Δ triple mutant by introducing an aco1Δ
mutation into anmrs3Δmrs4Δ doublemutant. DAPI staining
of the triple mutant showed that mtDNA was maintained
(Figure 4). Furthermore, quantitative analysis showed that
the percentage of rho0 cells in the triple mutant was 0.4%,
slightly lower than 2.5% in wild-type rho+ cells. The mrs3Δ
mrs4Δ aco1Δ triple mutant was also mated to a rho0 tester
strain and the resulting diploids were streaked onto plates
with ethanol as the sole carbon source. We found that the
diploids could grow on ethanol medium, indicating that
mtDNA in themrs3Δmrs4Δ aco1Δ triplemutant is functional
(data not shown). Together, this data supports the notion
that mtDNA loss in aco1Δ mutant cells is due to iron citrate
toxicity.
It has been reported that the supplementation of exoge-
nous iron (1mMFeSO
4
) or raising pH of the growthmedium
reduces petite frequency in aco1Δ mutant cells grown in
YPGalactose medium [17]. Thus, Lin et al. proposed that
some of the effects of elevated citrate levels in aco1Δ are
Oxidative Medicine and Cellular Longevity 7
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Figure 5: Citrate levels in wild-type (WT) and indicated mutant
strains. Citrate concentration was determined as described in
Section 2. The results are the average of two independent experi-
ments.
aco1Δ sod1Δ aco1Δ sod2Δ aco1Δ
Figure 6: A mutation in SOD1, but not SOD2, suppresses mtDNA
loss due to aco1Δ. Cells grown in YPD medium to mid-logarithmic
phase were stained with DAPI and examined using fluorescence
microscopy. aco1Δ, ZLY2630; sod1Δ aco1Δ, TPY1507; sod2Δ aco1Δ,
ZLY3973.
due to the ionized form of this metabolite rather than to
the formation of a citrate/iron chelate that could produce
oxidative damage to mtDNA. These observations seem to
contradict our conclusion. However, iron homeostasis is
a highly complicated process [44]. It was not established
that exogenous iron actually increased iron levels in the
mitochondria in Lin et al.’s study. It is also possible that
growth conditions (YPD in this study versus YPGalactose in
Lin et al.’s study) and/or strain backgrounds (BY4741 versus
W303-1B) may affect mtDNA loss associated with aco1Δ
mutations.
3.5. Iron Citrate Toxicity Correlates with mtDNA Loss in
aco1ΔMutant Cells. To affirmour hypothesis that iron citrate
toxicity contributes to mtDNA loss in aco1Δ mutant cells,
we determined citrate levels in wild-type and various mutant
strains and found that aco1Δ increased the citrate level by
10.5-fold (Figure 5), which is consistent with an 11.9-fold
increase reported by Lin et al. [17]. This increase is not due
to that aco1Δ mutants are rho0 cells since the citrate level
in wild-type rho0 cells was only 16% higher than that of
wild-type rho+ cells. Mutations in RTG1, RTG2, and RTG3
reduced citrate levels in aco1Δ background cells by 59–85%.
Similarly, cit1Δ reduced citrate concentration by 62% in aco1Δ
background cells, which is comparable to an 89% decrease
reported by Lin et al. A double mutation in CIT1 and CIT2
reduced citrate concentration by 98% in aco1Δ background
cells, and an additionalmutation inCIT3 did not significantly
further reduce citrate levels. Clearly, there is strong corre-
lation between the suppression of mtDNA loss phenotype
and lower citrate levels in aco1Δ background strains. We also
determined the effect of an mrs3Δ mrs4Δ double mutation
on citrate levels. In comparison to a wild-type rho+ strain,
citrate concentration in an mrs3Δ mrs4Δ double mutant was
53% lower. In contrast, citrate concentration in an mrs3Δ
mrs4Δ aco1Δ triplemutant is 24%higher than that of an aco1Δ
mutant. Since mrs3Δ mrs4Δ aco1Δ mutant cells maintained
mtDNA, we propose that high levels of citrate per se are
not sufficient to lead to mtDNA loss and that citrate toxicity
requires certain levels of iron in the mitochondria. Together
with our genetic data, these biochemical results suggest that
iron citrate toxicity accounts formtDNA loss in aco1Δmutant
cells.
3.6. A Mutation in SOD1, but Not SOD2, Prevents mtDNA
Loss due to aco1Δ. Our data suggest that high levels of citrate
cause mtDNA instability in aco1Δ mutant cells likely due
to iron citrate toxicity. Iron reacts with hydrogen peroxide
in the Fenton reaction to produce highly active, potent
hydroxyl radicals, which cause oxidative damage to mito-
chondria. Hydrogen peroxide is partly produced by the
superoxide dismutases, Sod1 in the cytoplasm and Sod2 in the
mitochondrial matrix [12]. We hypothesized that a reduced
production of hydrogen peroxide due to mutations in SOD1
or SOD2 might suppress mtDNA loss in aco1Δ mutant cells
by lowering the amount of hydroxyl radicals produced via
the Fenton reaction.Therefore, we generated sod1Δ aco1Δ and
sod2Δ aco1Δ double mutants by crossing respective haploid
mutant strains followed by meiotic segregation analysis. The
resultant double mutant strains were analyzed for mtDNA
presence by DAPI staining and fluorescence microscopy.
33 out of 34 sod1Δ aco1Δ double mutant strains generated
maintained mtDNA while 6 out of 6 sod2Δ aco1Δ double
mutants lost mtDNA (Figure 6 and data not shown). These
data suggest that hydrogen peroxide generated from reactions
catalyzed by Sod1 contributes tomtDNA loss in aco1Δmutant
cells. Mutations in SOD1 also cause oxidative damage due
to accumulation of superoxide radicals [15, 16]. However,
since an sod1Δ mutation suppressed mtDNA loss in aco1Δ
mutant cells, we propose that hydroxyl radicals are more
damaging to mtDNA than superoxide radicals. How would
mutations in the cytosolic isoform of superoxide dismutase
rescue a mitochondrial defect? It has been shown that a small
fraction of Sod1 is localized in the intermembrane space
of mitochondria, which protects cells from mitochondrial
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oxidative damage [45–47]. Why does not sod2Δ suppress
mtDNA loss associated with aco1Δ? It is possible that loss of
Sod2 leads to increased levels of superoxide radicals in the
mitochondria, which in the presence of ferrous ions would
cause any hydrogen peroxide produced in the mitochondria
to be converted to the hydroxyl radicals via the Fenton/Haber
Weiss reactions that damage mtDNA.
3.7. Loss of mtDNA in aco1ΔMutant Cells Is Growth Medium
Dependent. It has been proposed that mtDNA loss in aco1Δ
mutant cells is due to lack of physical protection of mtDNA
by Aco1 [20]. One key piece of evidence that supports this
hypothesis is the observation that the expression of two
catalytically inactive Aco1 mutants, Aco1𝐶382𝑆 and Aco1𝐶445𝑆,
under the control of the ADH1 promoter from the pRS416
centromeric plasmid, preventedmtDNA loss in aco1Δmutant
cells. To maintain the plasmids, transformants were grown
in YNBcasD medium. In light of discovery that iron citrate
toxicity contributes to mtDNA loss, one alternative expla-
nation for mtDNA retention in cells expressing ACO1𝐶382𝑆
and ACO1𝐶445𝑆 mutant alleles is due to differences in growth
medium, YNBcasD versus YPD. Accordingly, we trans-
formed aco1Δ/ACO1 heterozygous diploid mutant cells with
empty pRS416 vector and transformants were sporulated
and dissected on YPD or YNBcasD medium. Eleven aco1Δ
haploid mutants from a YPD dissection plate were obtained
and grown in YPD liquid medium andmtDNAwas observed
byDAPI staining.We found that all of the eleven aco1Δ segre-
gants lostmitochondrial DNA (Figure 7 and data not shown).
In contrast, amongnine aco1Δmutant segregants carrying the
empty pRS416 vector from a YNBcasD dissection plate that
were grown in YNBcasD liquid medium, seven maintained
mtDNA (Figure 7 and data not shown). When these seven
aco1Δ mutants containing mtDNA were passed onto YPD
plate medium twice and then grown in YPD liquid medium,
all lostmtDNA (data not shown). Together, these data suggest
that mtDNA loss in aco1Δ mutant cells is growth medium
dependent.
4. Conclusions
It has been proposed that yeast aconitase (Aco1) physically
binds to mtDNA and promotes its maintenance [20, 21]. Our
results in this study suggest a different, but not necessar-
ily mutually exclusive, mechanism. We propose that aco1Δ
activates the RTG pathway, resulting in increased citrate
production through upregulation of genes encoding citrate
synthase. Increased levels of citrate lead to iron overload in
the mitochondria. Iron then reacts with hydrogen peroxide
to generate hydroxyl radicals, which cause oxidative damage
tomitochondrial DNAand consequently its instability.Muta-
tions of yeast frataxin (Yfh1) lead to loss of activity of aconi-
tase [48]. Suppression of mtDNA instability due to mutations
in both YFH1 and ACO1 by reduced iron citrate levels raises
the possibility thatmtDNA loss in yfh1mutant cellsmay be an
indirect consequence of aconitase inactivation. Our data also
suggest that the cytosolic superoxide dismutase, Sod1, but not
aco1Δ (YNBCasD) aco1Δ (YPD)
Figure 7: mtDNA loss due to aco1Δ is growth medium dependent.
aco1Δ mutant cells (ZLY2630) carrying empty pRS416 vector were
grown in YNBcasD or YPD medium to mid-logarithmic phase,
stained with DAPI, and examined using fluorescence microscopy.
the mitochondrial superoxide dismutase, Sod2, contributes
to mtDNA loss in aco1Δmutant cells.
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